GlobalData on MSN11h
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drug
The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Fintel on MSN9h
Leerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform Recommendation
Fintel reports that on March 17, 2025, Leerink Partners initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...
The Manila Times16h
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...
Nuvation Bio Inc. (NYSE:NUVB) Receives Average Rating of “Buy” from Analysts
Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have been assigned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports.